Advanced search
Publication Cover
Expert Opinion on Orphan Drugs Volume 6, 2018 - Issue 2
Submit an article Journal homepage
90
Views
2
CrossRef citations to date
0
Altmetric
Original Research

Orphan medicinal products’ access to the Bulgarian pharmaceutical market – challenges and obstacles

Maria KamushevaFaculty of Pharmacy, Medical University-Sofia, Sofia, BulgariaCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0002-4379-5283View further author information
ORCID Icon,
Konstantin TachkovFaculty of Pharmacy, Medical University-Sofia, Sofia, BulgariaView further author information
,
Guenka PetrovaFaculty of Pharmacy, Medical University-Sofia, Sofia, BulgariaORCID Iconhttp://orcid.org/0000-0001-8116-5138View further author information
ORCID Icon,
Alexandra SavovaFaculty of Pharmacy, Medical University-Sofia, Sofia, BulgariaView further author information
&
Manoela ManovaFaculty of Pharmacy, Medical University-Sofia, Sofia, BulgariaView further author information
Pages 95-104 | Received 02 Nov 2017, Accepted 19 Dec 2017, Published online: 28 Dec 2017

Citations (2)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Maria Stefanova Kamusheva & Maria Jordanova Dimitrova. (2020) Clinical and economic assessment of nusinersen: the Bulgarian perspective. Expert Opinion on Orphan Drugs 8:10, pages 403-415.
Read now

Articles from other publishers (1)

Maria Kamusheva, Mariya Vassileva, Alexandra Savova, Manoela Manova & Guenka Petrova. (2018) An Overview of the Reimbursement Decision-Making Processes in Bulgaria As a Reference Country for the Middle-Income European Countries. Frontiers in Public Health 6.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.